That somewhere else is often muscle
While a guest on the "Club Shay Shay" podcast, Iglesias explained why he ditched the GLP-1 that seemed to be working: "The problem with Ozempic is you're going to lose more muscle than fat." A 2024 review in Diabetes, Obesity, and Metabolism supports his assertion to an extent, stating that studies show GLP-1 use may cause the loss of up to 60% of a person's total lean muscle
This is the most challenging period mentally and physically
Moreover, CUD has been associated with a higher risk for psychotic disorders [7, 8], self-harm, and suicidal behaviors [9,10,11]
Its best to avoid both several hours before bedtime
4 Concluding remarks, place in therapy, and future perspective Tirzepatide is a novel agent that is approved for the treatment of type 2 diabetes and will likely be approved for weight loss